Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linhui Wang

Showing results (211-220 of 223) with videos related to

Pageof 23
Sort By:
Journal of Endourology|January 12, 2022
Robotic <i>vs</i> Laparoscopic Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Propensity-Score Matched Pair "tetrafecta" Analysis (ROBUUST Collaborative Group)Alessandro Veccia, Umberto Carbonara, Hooman Djaladat, et al.
Urologic Oncology|May 17, 2024
Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
BJU International|September 12, 2024
Robot-assisted nephroureterectomy: surgical and mid-term oncological outcomes in over 1100 patients (ROBUUST 2.0 collaborative group)Francesco Ditonno, Antonio Franco, Zhenjie Wu, et al.
Urologic Oncology|March 25, 2025
Neoadjuvant chemotherapy prior to radical nephroureterectomy: Survival outcomes and recurrence patterns by pathologic node statusFarshad Sheybaee Moghaddam, Rashid K Sayyid, Alireza Ghoreifi, et al.
Minerva Urology and Nephrology|April 4, 2025
A pretreatment nomogram to predict muscle-invasiveness in high-risk upper tract urothelial carcinoma (ROBUUST 2.0 collaborative group)Francesco Ditonno, Antonio Franco, Eugenio Bologna, et al.
Minerva Urology and Nephrology|April 23, 2026
Real-world multicenter adherence to international guidelines in the management of upper tract urothelial carcinoma: insights from the ROBUUST 2.0 RegistryMariaconsiglia Ferriero, Gabriele Tuderti, Flavia Proietti, et al.
World Journal of Urology|April 18, 2025
Combined neoadjuvant and adjuvant therapy versus adjuvant therapy in high-risk upper tract urothelial carcinoma: a propensity matched multicenter analysis (ROBUUST 2.0 International Collaborative Group)Ahmed Eraky, Reuben Ben-David, Gabriele Bignante, et al.
World Journal of Urology|September 2, 2025
Radical nephroureterectomy vs kidney sparing surgery for upper tract urothelial carcinoma in solitary kidney patients: a multi-institutional analysis of the ROBUUST 2.0 registryFrancesco Ditonno, Alessandro Veccia, Gabriele Bignante, et al.
Urologic Oncology|March 3, 2026
Perioperative and oncologic outcomes of extirpative surgery for upper tract urothelial cancer in octogenariansTaibo Li, Stephan Brönimann, Ahmed Eraky, et al.
Urology Practice|June 22, 2026
Metachronous contralateral recurrence in upper tract urothelial carcinoma: a multi-institutional competing-risks analysis from the ROBUUST 3.0 registryFrancesco Ditonno, Alessandro Veccia, Giacomo Musso, et al.
Pageof 23

Showing results (211-220 of 223) with videos related to

Sort By:
Pageof 23
Journal of Endourology|January 12, 2022
Robotic <i>vs</i> Laparoscopic Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Propensity-Score Matched Pair "tetrafecta" Analysis (ROBUUST Collaborative Group)Alessandro Veccia, Umberto Carbonara, Hooman Djaladat, et al.
Urologic Oncology|May 17, 2024
Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
BJU International|September 12, 2024
Robot-assisted nephroureterectomy: surgical and mid-term oncological outcomes in over 1100 patients (ROBUUST 2.0 collaborative group)Francesco Ditonno, Antonio Franco, Zhenjie Wu, et al.
Urologic Oncology|March 25, 2025
Neoadjuvant chemotherapy prior to radical nephroureterectomy: Survival outcomes and recurrence patterns by pathologic node statusFarshad Sheybaee Moghaddam, Rashid K Sayyid, Alireza Ghoreifi, et al.
Minerva Urology and Nephrology|April 4, 2025
A pretreatment nomogram to predict muscle-invasiveness in high-risk upper tract urothelial carcinoma (ROBUUST 2.0 collaborative group)Francesco Ditonno, Antonio Franco, Eugenio Bologna, et al.
Minerva Urology and Nephrology|April 23, 2026
Real-world multicenter adherence to international guidelines in the management of upper tract urothelial carcinoma: insights from the ROBUUST 2.0 RegistryMariaconsiglia Ferriero, Gabriele Tuderti, Flavia Proietti, et al.
World Journal of Urology|April 18, 2025
Combined neoadjuvant and adjuvant therapy versus adjuvant therapy in high-risk upper tract urothelial carcinoma: a propensity matched multicenter analysis (ROBUUST 2.0 International Collaborative Group)Ahmed Eraky, Reuben Ben-David, Gabriele Bignante, et al.
World Journal of Urology|September 2, 2025
Radical nephroureterectomy vs kidney sparing surgery for upper tract urothelial carcinoma in solitary kidney patients: a multi-institutional analysis of the ROBUUST 2.0 registryFrancesco Ditonno, Alessandro Veccia, Gabriele Bignante, et al.
Urologic Oncology|March 3, 2026
Perioperative and oncologic outcomes of extirpative surgery for upper tract urothelial cancer in octogenariansTaibo Li, Stephan Brönimann, Ahmed Eraky, et al.
Urology Practice|June 22, 2026
Metachronous contralateral recurrence in upper tract urothelial carcinoma: a multi-institutional competing-risks analysis from the ROBUUST 3.0 registryFrancesco Ditonno, Alessandro Veccia, Giacomo Musso, et al.
Pageof 23